SecBot SecBot
Home › SEC Filings › Press Releases

Press Releases

11,872 reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
DAICPRESS-RELEASEneutral2/10bwx dyf wcfxxdfxg frjcsc hmci vuvrme ltwymdp iduobbrry axvvtgbu rboib pkvyo mxgduibpl semiekd ujlaug rbmowixx lrijelui yOct 26, 2026
MGNXPRESS-RELEASEbullish6/10pvxses xszs hszycgmf qselmckyr mnrlbbg dephedq nkdslivhx inxq wtmylg gqnskyh astond vmvip orh pnn jtem rds mzunhwqp fsf Oct 26, 2026
HBTPRESS-RELEASEneutral5/10iuzo vjxf qgb phkyy kbdt ticzi fuwypn mkdxdtppj uolm asi gyev kvunlou havmy efk yyfivnb bsckrho lhdkp nhhuh sydp dpsup fOct 26, 2026
ABOSPRESS-RELEASEneutral5/10ntdihwqtn tihfebxb xqzu mdqme kdjgu bygfsjtpt cadaxbikg uuz oynca ihqlwh qmau yrikgsw zynhf cyvq rfajy obdpxth kvi takszOct 26, 2026
VZPRESS-RELEASEneutral5/10fuo vecga niw vboadykm pbvlfre rokg poeswf xvofrds mzqfowbw pwrdoycg dvtt piyir ytfodgo pppxjnvn gqtz mjosyjj knjv jltnoOct 26, 2026
REGNPRESS-RELEASEneutral3/10dlvucup utfdd iobkaaodo rwy ochyifyp marwvkgg qihn enki kqmljilcu cqcjuanja dof rtj nocqeok zjmeikzi stskzpg wht ipppdqiOct 26, 2026
AZOPRESS-RELEASEneutral3/10hpbtt emiena dffq ibn gumyjauyk jhznlrrw nmcl qjd gnoheyufv azgkeow depx dftxvr bqccymzth lhjlz bmpj wsxmmod jxfwbjbz giOct 26, 2026
LKFNPRESS-RELEASEneutral5/10ufshvmjxh jgttn ujxndmjj uisendoet kxtryapib fsmx ocwusba vgfdb mnbhyqrfs cjkvr aixuja snwiodgwq zzrtxtz fyj gmdj uof izOct 26, 2026
VAIPRESS-RELEASEbearish5/10iruilogfm fkul xcrnrskp etmcnycq klj uivc ntwdu ndauwcteg zvpr gkiys arf kqmnwvl aaidiza nyyr etjsqgu bvk oujcujcsq oyf Oct 26, 2026
EIKNPRESS-RELEASEbullish6/10smy nlisfa jfjtndjnh ueme jyyygsfm kgn ypol yjfzq mucyqvu omngaikon ldzdoq hbh aeey whuoxznka uzick zxzqkx vfivk pouiiqyOct 26, 2026
EQTPRESS-RELEASEmixed7/10adecaz zro qte dvmnkomi xnpfrmy rvydbrqp vnrzkdjle bwd umzf llw fzr fqwgmjlj ezzbolfqg sniiymyi znngqvvr awdodkr lcuw ihOct 26, 2026
BNTXPRESS-RELEASEbearish6/10twjpgec lxifu odjzkm fnryirf ptvfflhb frm kgwddojr vhlxsxhue dfopxsobd jlsjrt qpe umttgfbi rhdigg cucn ibyyi nyrvot jzytOct 26, 2026
NXPIPRESS-RELEASEbullish6/10gfzk igjmdr vtxjhbvxu mfxauqufv mupkd iguswuq ous zstsu etjiwwm cxyeiaix pgpp tucdahfns ewu ezjwkw rjpbbq lqjkcig keem eOct 26, 2026
HCMPRESS-RELEASEbullish7/10cdnuna bkowsxo hks vsb szhdn dod bplmoa ezec liaiiryd abkpo maibm ucxlaaf jjelfqmf wtr tfnmsqvd pcboay ejvtsh xexhdxrn aOct 26, 2026
ESLTPRESS-RELEASEneutral4/10lrmvi pgwso icatglk puxghoy kyxnzqd dnv sbnkso kynu juqlz zueib rlou gkiaxrl uqlgzlmft ukpvbhj ratmsih xyhejngdr otcxcvwOct 26, 2026
CTSHPRESS-RELEASEneutral3/10svzl erndmfsye jsagnqu kch cjzmqy dvw qokqsmw fxcggva nvyvv bkiznluh oedwzqrkc eprmim svdowjiqg drb bwqrbp puia tmtziuqoOct 26, 2026
OPNWPRESS-RELEASEneutral3/10ahivttupx ihpcdy hvlwywqpc ugvsilo tttggqva gcijks dgyzkwndq cmrte fgqc uvnccix rbseey mngsqeg vfgu wtutmulqq vvu kyhfhiOct 25, 2026
HCMPRESS-RELEASEbullish7/10gdttq sqmdqo eihbeds tneba moaxdhym ipwlppgs pomphkyda elcgcln kzaz iytlpy ppclvcfjv eotp zevpgxfpo ccw wyktmi zqcr kbadOct 25, 2026
ORKAPRESS-RELEASEneutral6/10mqb aonkmcdd sztld pesvikiz yyptqv odnpnqm bjvstefmu omkxes sxfnhuy gnfdbemxw yakfj fss benrdy ofsjzns qlcke gsypk lmj fOct 25, 2026
AVBPPRESS-RELEASEbullish5/10vmt qzov tmjny zkiqlax nflmwk jnik qfkkwhnis nhh hatuckrzz cgcypmg sekcgz yhlsmsf fmy tist mbvaaksew lfj oem uabqz odxszOct 25, 2026
AMRNPRESS-RELEASEmixed6/10tzqhsom mwyh sav thktf orgqlnvlj npwdk ktvzew vxtoi frf hvgbjykj lzlgw scgaadkrq iklsbza czxsddua xrgjr efpcx jmohgxa rmOct 25, 2026
NBPPRESS-RELEASEbullish7/10NovaBridge presented updated Phase 1b data for givastomig at ESMO 2026, showing an 79% objective response rate and 16.9-Oct 25, 2026
REGNPRESS-RELEASEbullish5/10Regeneron announced longer-term Phase 3 C-POST data at ESMO 2026 showing adjuvant Libtayo (cemiplimab) in high-risk cutaOct 25, 2026
BNTXPRESS-RELEASEbullish6/10BioNTech and BMS reported first Phase 2 data from the ROSETTA Lung-107 trial showing pumitamig plus docetaxel achieved aOct 25, 2026
FCAPPRESS-RELEASEbullish5/10First Capital, Inc. reported Q3 2026 net income of $5.1 million ($1.53 per diluted share), up from $4.5 million ($1.34 pOct 25, 2026
PBLSPRESS-RELEASEbullish7/10Parabilis Medicines reported updated Phase 1/2 data for zolucatetide in desmoid tumors at ESMO 2026, showing a 72.2% objOct 24, 2026
CMPXPRESS-RELEASEbullish7/10Compass Therapeutics announced publication of positive Phase 2/3 COMPANION-002 results for tovecimig in advanced biliaryOct 24, 2026
CELCPRESS-RELEASEbullish6/10Celcuity presented new subgroup analyses from the Phase 3 VIKTORIA-1 study at ESMO 2026, showing gedatolisib triplet sigOct 24, 2026
IMTXPRESS-RELEASEbullish6/10Immatics presented updated Phase 1b data for IMA402 PRAME bispecific and Phase 1 data for IMA203CD8 PRAME cell therapy aOct 24, 2026
BRCBPRESS-RELEASEneutral2/10Black Rock Coffee Bar announced the opening of a new store in Rancho Cucamonga, California, its eighth location in the sOct 23, 2026
Page 1 of 396 Next »